Medicare Enrolled

Dr. Norman Lowenbraun, M.D.

Cardiovascular Disease · San Jose, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
173 N MORRISON AVE, San Jose, CA 95126
4082931992
In practice since 2006 (19 years)
NPI: 1962448530 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lowenbraun from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lowenbraun? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Lowenbraun

Dr. Norman Lowenbraun is a cardiovascular disease specialist in San Jose, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Lowenbraun performed 8,344 Medicare services across 2,113 unique beneficiaries.

Between the years covered by Open Payments, Dr. Lowenbraun received a total of $6,255 from 23 pharmaceutical and/or device companies across 240 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Lowenbraun is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 8% volume in CA $6,255 industry payments

Medicare Practice Summary

Medicare Utilization ↗
8,344
Medicare services
Top 8% in CA for cardiovascular disease
2,113
Unique beneficiaries
$74
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~439 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Adenosine injection, 1 mg
Administration of a 1 mg dose of adenosine medication. This code is specifically for adenosine and excludes adenosine phosphate compounds.
4,812 $0 $5
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
1,027 $110 $190
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
893 $1 $6
Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries 242 $417 $600
Echocardiogram, transthoracic
An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function.
223 $200 $800
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
180 $13 $48
Exercise or drug-induced heart stress test with ECG
A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review.
149 $72 $250
Nuclear stress test of heart muscle
A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress.
120 $1,605 $3,500
2-day continuous ECG with review and report
A two-day continuous electrocardiogram recording that includes a professional review and written report of the results.
114 $70 $275
Continuous ECG monitoring, up to 30 days
Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results.
108 $23 $36
30-day continuous ECG with patient-triggered event transmission and review
This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report.
107 $956 $1,275
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
93 $71 $141
New patient office visit, complex (60-74 min) 86 $191 $382
Regadenoson injection (Lexiscan) for heart stress test
An injection of regadenoson, a medication used to stress the heart during diagnostic testing.
76 $45 $75
Pacemaker programming, dual lead system
Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings.
49 $74 $120
Technetium Tc-99m sestamibi diagnostic injection
A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies.
22 $89 $225
Pacemaker system evaluation
Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems.
18 $47 $80
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
14 $165 $309
Nuclear stress test of heart muscle
A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera.
11 $451 $900
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
14.2% high complexity
62.2% medium
23.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$6,255
Total received (2018-2024)
Avg $894/year across 7 years
Top 36% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
240
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,805 (92.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$450 (7.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,280
2023
$923
2022
$434
2021
$96
2020
$786
2019
$1,166
2018
$569

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$1,229
PFIZER INC.
$212
Abbott Laboratories
$205
Amgen Inc.
$200
Edwards Lifesciences Corporation
$153
Janssen Pharmaceuticals, Inc
$86
Merck Sharp & Dohme LLC
$70
Novartis Pharmaceuticals Corporation
$62
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$27
Kiniksa Pharmaceuticals International, plc
$21
Esperion Therapeutics, Inc.
$15
Top 3 companies account for 72.2% of 2024 payments
All-time payments by company (2018-2024) ›
Boston Scientific Corporation
$1,488
PFIZER INC.
$822
Janssen Pharmaceuticals, Inc
$477
Boehringer Ingelheim Pharmaceuticals, Inc.
$430
Amgen Inc.
$400
Amarin Pharma Inc.
$376
Novartis Pharmaceuticals Corporation
$361
BIOTRONIK INC.
$360
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$288
Abbott Laboratories
$205
Edwards Lifesciences Corporation
$153
Merck Sharp & Dohme LLC
$149
Novo Nordisk Inc
$125
ABIOMED
$125
E.R. Squibb & Sons, L.L.C.
$113
AtriCure, Inc.
$111
AstraZeneca Pharmaceuticals LP
$93
Kowa Pharmaceuticals America, Inc.
$42
Esperion Therapeutics, Inc.
$36
BOSTON SCIENTIFIC CORPORATION
$35
Kiniksa Pharmaceuticals, Ltd.
$26
Kiniksa Pharmaceuticals International, plc
$21
Regeneron Healthcare Solutions, Inc.
$20
Top 3 companies account for 44.6% of all-time payments
Associated products mentioned in payments ›
AMPLATZER AMULET · Arcalyst · BRILINTA · CHANTIX · Corlanor · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENTRESTO · Epi-Sense Guided Coagulation System with VisiTrax · Impella · JARDIANCE · LEQVIO · LifeVest · Livalo · Models · NEXLETOL · PRADAXA · PRALUENT · Repatha · Rivacor 7 DR-T · VERQUVO · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (93%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a cardiovascular disease specialist in San Jose?
Compare cardiologists in the San Jose area by procedure volume, costs, and industry payment transparency.
Browse cardiologists nearby

Geographic Context

Cardiologists within 10 mi
207
Per 100K population
10.9
County median income
$159,674
Nearest hospital
SANTA CLARA VALLEY MEDICAL CENTER
1.3 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Lowenbraun is a mixed practice specialist, with above-average Medicare volume (top 8% in CA), with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Lowenbraun experienced with adenosine injection, 1 mg?
Based on Medicare claims data, Dr. Lowenbraun performed 4,812 adenosine injection, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lowenbraun receive payments from pharmaceutical companies?
Yes. Dr. Lowenbraun received a total of $6,255 from 23 companies across 240 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lowenbraun's costs compare to other cardiologists in San Jose?
Dr. Lowenbraun's average Medicare payment per service is $74. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lowenbraun) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →